Free Trial

Rockefeller Capital Management L.P. Acquires Shares of 139,489 Grail, Inc. (NASDAQ:GRAL)

Grail logo with Medical background

Rockefeller Capital Management L.P. bought a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 139,489 shares of the company's stock, valued at approximately $2,490,000. Rockefeller Capital Management L.P. owned approximately 0.42% of Grail as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Sterling Capital Management LLC purchased a new stake in shares of Grail during the fourth quarter valued at about $29,000. Treasurer of the State of North Carolina acquired a new stake in Grail in the fourth quarter valued at approximately $208,000. Raymond James Financial Inc. purchased a new position in Grail in the fourth quarter worth $476,000. Arbiter Partners Capital Management LLC purchased a new position in Grail in the fourth quarter worth $14,827,000. Finally, Legal & General Group Plc acquired a new position in shares of Grail during the fourth quarter worth $1,292,000.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on GRAL shares. Morgan Stanley increased their price target on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th. Canaccord Genuity Group started coverage on shares of Grail in a report on Monday. They issued a "buy" rating and a $32.00 price target for the company.

Check Out Our Latest Stock Report on Grail

Insider Buying and Selling at Grail

In other news, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the transaction, the president now directly owns 559,673 shares of the company's stock, valued at $17,461,797.60. The trade was a 0.38 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the sale, the chief financial officer now directly owns 335,170 shares in the company, valued at $10,457,304. This trade represents a 0.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 11,550 shares of company stock valued at $360,436.

Grail Stock Performance

GRAL traded up $3.91 during trading on Thursday, reaching $37.67. 994,111 shares of the company's stock were exchanged, compared to its average volume of 1,224,588. The company's fifty day simple moving average is $31.69 and its 200-day simple moving average is $23.92. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. On average, analysts anticipate that Grail, Inc. will post -15.15 EPS for the current year.

About Grail

(Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Featured Articles

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Should You Invest $1,000 in Grail Right Now?

Before you consider Grail, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.

While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines